Mumbai: Investors who have received shares of the recently help Gujarat Kidney and Super Speciality Ltd IPO will get their allotted shares by the end of the day on December 26, 2025. The IPO, held between December 22 to 24, saw the issue oversubscribed by 5.21 times, with the retail category oversubscribed 19.04 times, the NII category was subscribed 5.73 times while the QIB category was oversubscribed 1.06 times.
The ₹250.80 crore IPO was priced at ₹108 to ₹114 per share, an entirely fresh issue of 2.20 crore equity shares. The Vadodara, Gujarat-based company operates a hospital specialising in various high-end specialities, including nephrology, urology, renal transplantation, cardiology, neurology, oncology and other allied disciplines.
The company aims to use the proceeds to partly pay for its newly acquired hospital, ‘Ashwini Medical Centre’, while funding its new expansion endeavours, including the acquisition of new hospitals, equipmen,t and to repay its existing debt obligations.
The company’s Grey Market Premium (GMP), the unofficial indicator of investor interest, has remained 0 since the issue closed on December 24. In fact, the GMP never moved beyond 8.77% from December 18, as per Investorgain data.
Shareholders can check their allotment status on this link, pick ‘Gujarat Kidney and Super Speciality Ltd’ from the IPO names, mention your DP/Client ID and other details and hit ‘Submit’.
The shares will be listed on the BSE and NSE on December 30, 2025.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investing in stocks includes financial risks, and past performance is not indicative of future results. Readers should conduct their own research or consult with a qualified financial advisor before making any investment decisions.
